![Prediction of the treatment response in ovarian cancer: a ctDNA approach | Journal of Ovarian Research | Full Text Prediction of the treatment response in ovarian cancer: a ctDNA approach | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00729-1/MediaObjects/13048_2020_729_Figa_HTML.png)
Prediction of the treatment response in ovarian cancer: a ctDNA approach | Journal of Ovarian Research | Full Text
![Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo- controlled, phase 2b trial - The Lancet Oncology Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo- controlled, phase 2b trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7be0eb01-da1f-44a6-9f5c-d325592b5d81/gr1.gif)
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo- controlled, phase 2b trial - The Lancet Oncology
![Tools in the pharmacologic arsenal for treatment of ovarian cancer.... | Download Scientific Diagram Tools in the pharmacologic arsenal for treatment of ovarian cancer.... | Download Scientific Diagram](https://www.researchgate.net/publication/326987371/figure/fig1/AS:658963540496385@1534120559760/Tools-in-the-pharmacologic-arsenal-for-treatment-of-ovarian-cancer-SERM-selective.png)
Tools in the pharmacologic arsenal for treatment of ovarian cancer.... | Download Scientific Diagram
![JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer](https://df6sxcketz7bb.cloudfront.net/manuscripts/133000/133247/medium/jci.insight.133247.f2.jpg)
JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
![JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer](https://df6sxcketz7bb.cloudfront.net/manuscripts/133000/133247/medium/jci.insight.133247.f1.jpg)
JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
![An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor - Gynecologic An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor - Gynecologic](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/71537546-3aa5-4aff-a444-b2c79f9091b4/gr1.jpg)
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor - Gynecologic
![Chemotherapy of ovarian cancer (Chapter 26) - Altchek's Diagnosis and Management of Ovarian Disorders Chemotherapy of ovarian cancer (Chapter 26) - Altchek's Diagnosis and Management of Ovarian Disorders](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:99369:20160618002055865-0746:01281tbl26_1.png?pub-status=live)
Chemotherapy of ovarian cancer (Chapter 26) - Altchek's Diagnosis and Management of Ovarian Disorders
![Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome - European Journal of Cancer Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4a58df59-ad06-4e76-8893-30d8ac6ad976/gr1.jpg)
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome - European Journal of Cancer
![Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline - Gynecologic Oncology Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2111891580/2083833650/gr1.jpg)